RxDoctor Payments Data

Katelin Pannell, MD

Family Medicine · Hixson, TNNPI 1255838165

Payments from drug & device makers

$7,959in general payments, 2019–2025

Across 454 payments — averaging $17.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AstraZeneca$832
  • AbbVie$814
  • Lilly USA, LLC$653
  • Amgen$623
  • Bayer$556
  • plus $3K from 33 others

What the payments were for

  • Food & beverage$7,959100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,959 in reported general payments places this provider in the 85th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$40,659
Medicare patients
146
Services billed
457

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin66$86,711
OzempicSemaglutide49$66,167
FarxigaDapagliflozin Propanediol57$54,790
EliquisApixaban34$44,516
RybelsusSemaglutide24$26,081
TrulicityDulaglutide16$16,846
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$14,051
MounjaroTirzepatide14$13,971
XareltoRivaroxaban14$9,997
Lantus SolostarInsulin Glargine,hum.Rec.Anlog24$4,168
Dexlansoprazole DrDexlansoprazole14$3,661
Humalog Mix 75-25Insulin Lispro Protamin/Lispro13$3,529
Atorvastatin Calcium294$3,462
Insulin Lispro Kwikpen U-100Insulin Lispro15$3,341
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen90$2,999

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$1,055$92,24873 claims
Boehringer IngelheimJardiance$367$86,71166 claims
AstraZenecaFarxiga$832$54,79057 claims
PfizerEliquis$485$44,51634 claims
Lilly USA, LLCTrulicity, Mounjaro, Humalog Mix 75-25$653$34,34543 claims
GSKTrelegy Ellipta$258$14,05120 claims
Johnson & JohnsonXarelto$48$9,99714 claims
AbbVieSynthroid$814$1,27612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Hixson

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →